Status:
NOT_YET_RECRUITING
Clinical Study on the Treatment of Anorexia and Cachexia in Advanced Gastric and Esophageal Cancer With Nanosized Megestrol Acetate Combined With Immunochemotherapy
Lead Sponsor:
Peking University
Conditions:
Advanced Gastroesophageal Cancer
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
This study is a prospective, randomized, parallel-controlled, multicenter clinical study. The purpose of this study is to evaluate the efficacy and safety of nanocrystalline megestrol acetate combined...
Eligibility Criteria
Inclusion
- Aged between 18 and 75 years old, regardless of gender；
- The Eastern Cooperative Oncology Group (ECOG) performance status score is 0-2；
- The expected survival time is more than 3 months；
- Good organ function
Exclusion
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT06963593
Start Date
June 1 2025
End Date
August 31 2027
Last Update
May 9 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.